menu Home

Program - Day 2 (Sep. 1, 2024)

Click the Button to check time for each country where you are located.




Room A

Time Program Chair / Speaker
08:30-09:20 Morning Session
KIM Dong Hyun
(Korea)
A Reality Check: Achieving Complete Clear Skin in PsO with Bx in Real Life Setting YAMANAKA Keiichi
(Japan)
09:20-10:30 Updated Understanding of Pustular Psoriasis SHIN Bong Seok
(Korea)
Morita Akimichi
(Japan)
09:20-09:40 Clinical Picture and Diagnosis of PPP KOBAYASHI Satomi
(Japan)
09:40-10:00 Pathophysiology / Mechanism in PPP MAN Xiao-Yong
(China)
10:00-10:20 GPP: Challenges and Opportunities of the Flare GUEVARA Bryan
(Philippines)
10:20-10:30 Q & A and Discussion  
10:30-11:00 Coffee Break and E-Poster Rounding
11:00-12:10 Panel Discussion #4
Tailored Biologic Treatment Strategies
TADA Yayoi
(Japan)
TSAI Tsen-Fang
(Chinese Taipei)
CHOON Siew Eng
(Malaysia)
11:00-11:10 Selecting Patients for Biologic Therapy (with Case Presentation) LACONICO-TUMALAD Lily Lyralin
(Philippines)
11:10-11:20 Choosing the Right Biologic Therapy (with Case Presentation) YAMAZAKI Fumikazu
(Japan)
11:20-11:30 Switching Biologics: from Failure to Success (with Case Presentation) NAM Kyung-Hwa
(Korea)
11:30-11:40 Managing Adverse Reactions (with Case Presentation) ZHAO Yi
(China)
11:40-12:10 Panel Discussion TADA Yayoi
(Japan)
TSAI Tsen-Fang
(Chinese Taipei)
CHOON Siew Eng
(Malaysia)
12:10-13:30 Luncheon Symposium #3
LEE Joo Heung
(Korea)
Long-term Remissions of Psoriatic Disease: Are We There yet? PRAJAPATI Vimal
(Canada)
13:30-14:30 Optimizing Conventional Therapy Outcomes in Mild-to-Moderate Patients KIM Kwang Ho
(Korea)
WAHYUDI Danang Tri
(Indonesia)
13:30-13:50 Optimization of Topical Treatments and Phototherapy JUNG So Young
(Korea)
13:50-14:10 Immunomodulators (Cyclosporin, MTX) NAM Kyung-Hwa
(Korea)
14:10-14:30 Systemic Options Other than Cyclosporine and Methotrexate (Acitretin, DMF) KIM Yoon-Seob
(Korea)
14:30-15:00 General Assembly  
15:00 Closing  

Room B

Time Program Chair / Speaker
08:30-09:20 Selected Highlights
(Posters of Interest)
PARK Joonsoo
(Korea)
IKEDA Shigaku
(Japan)
   
09:20-10:30 A Holistic Approach to Psoriatic Comorbidities LEE Weon Ju
(Korea)
AZURA Mohd Affandi
(Malaysia)
09:20-09:40 Management of PsA and Challenging Cases YAMANAKA Keiichi
(Japan)
09:40-10:00 Psoriasis Patients with Cardiovascular Risks KIM Jeong Eun
(Korea)
10:00-10:20 Mental Health of Psoriasis Patients CHI Ching-Chi
(Chinese Taipei)
10:20-10:30 Q & A and Discussion  
10:30-11:00 Coffee Break and E-Poster Rounding
11:00-11:30 Invited Lecture #4 YAMAGUCHI Yukie
(Japan)
SHI Yuling
(China)
Biomarker of Psoriasis LEE Eun-So
(Korea)
11:30-12:00 Invited Lecture #5 ROH Joo Young
(Korea)
SETOYAMA Mitsuru
(Japan)
Psoriasis Management Strategies for Long-Term Remission: Where Are We in a New Era ZHENG Min
(China)
12:10-13:30 Luncheon Symposium #4
PARK Chul Jong
(Korea)
The Role of Early Intervention with Secukinumab in Psoriasis Disease Modification: Insights from the STEPIn Study & Recent Research CONRAD Curdin
(Switzerland)
13:30-14:30 Psoriasis in Special Condition Kim Hei Sung
(Korea)
SEMCHIN Munkhbayar
(Mongolia)
13:30-13:50 Treatment of Pediatric Patients KIM Sung Ae
(Korea)
13:50-14:10 Treatment of Patients with Active Cancer JUNG Joon Min
(Korea)
14:10-14:30 Treatment of Patients with Infection JUNG Hye Jung
(Korea)
14:30-15:00 General Assembly  
15:00 Closing  
Go to Top